LBA3 Treatment with tumor-infiltrating lymphocytes (TIL) versus ipilimumab for advanced melanoma: Results from a multicenter, randomized phase III trial
| Autor: | Haanen, J.B.A.G., Rohaan, M., Borch, T.H., van den Berg, J.H., Met, Ö., Foppen, M. Geukes, Granhøj, J. Stoltenborg, Nuijen, B., Nijenhuis, C., Beijnen, J.H., Jedema, I., van Zon, M., Noringriis, I. Mansfield, Kessels, R., Wilgenhof, S., van Thienen, H.V., Lalezari, F., van Akkooi, A.C.J., Donia, M., Svane, I-M. |
|---|---|
| Zdroj: | In Annals of Oncology September 2022 33 Supplement 7:S1406-S1406 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|